Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

The effect of a large regional health plan's value-based insurance design program on statin use.

Frank MB, Fendrick AM, He Y, Zbrozek A, Holtz N, Leung S, Chernew ME.

Med Care. 2012 Nov;50(11):934-9. doi: 10.1097/MLR.0b013e31826c8630.

PMID:
23047782
2.

Value-based insurance design program in north Carolina increased medication adherence but was not cost neutral.

Maciejewski ML, Wansink D, Lindquist JH, Parker JC, Farley JF.

Health Aff (Millwood). 2014 Feb;33(2):300-8. doi: 10.1377/hlthaff.2013.0260.

PMID:
24493774
3.

Medication adherence changes following value-based insurance design.

Farley JF, Wansink D, Lindquist JH, Parker JC, Maciejewski ML.

Am J Manag Care. 2012 May;18(5):265-74.

4.
5.

The impact of reducing cardiovascular medication copayments on health spending and resource utilization.

Choudhry NK, Fischer MA, Avorn JL, Lee JL, Schneeweiss S, Solomon DH, Berman C, Jan S, Lii J, Mahoney JJ, Shrank WH.

J Am Coll Cardiol. 2012 Oct 30;60(18):1817-24. doi: 10.1016/j.jacc.2012.06.050. Epub 2012 Oct 3.

6.

Impact of statin copayments on adherence and medical care utilization and expenditures.

Gibson TB, Mark TL, Axelsen K, Baser O, Rublee DA, McGuigan KA.

Am J Manag Care. 2006 Dec;12 Spec no.:SP11-9.

7.
8.

Copayment reductions generate greater medication adherence in targeted patients.

Maciejewski ML, Farley JF, Parker J, Wansink D.

Health Aff (Millwood). 2010 Nov;29(11):2002-8. doi: 10.1377/hlthaff.2010.0571.

9.

Patient-centered outcomes of a value-based insurance design program for patients with diabetes.

Elliott DJ, Robinson EJ, Anthony KB, Stillman PL.

Popul Health Manag. 2013 Apr;16(2):99-106. doi: 10.1089/pop.2012.0031. Epub 2013 Feb 13.

PMID:
23405873
10.

The impact of a value-based insurance design plus health coaching on medication adherence and medical spending.

Musich S, Wang S, Hawkins K.

Popul Health Manag. 2015 Jun;18(3):151-8. doi: 10.1089/pop.2014.0081. Epub 2014 Sep 23.

PMID:
25247449
11.

Value-based insurance design in Medicare.

Encinosa WE.

Appl Health Econ Health Policy. 2009;7(3):149-54. doi: 10.2165/11318720-000000000-00000.

PMID:
19799469
12.

Five features of value-based insurance design plans were associated with higher rates of medication adherence.

Choudhry NK, Fischer MA, Smith BF, Brill G, Girdish C, Matlin OS, Brennan TA, Avorn J, Shrank WH.

Health Aff (Millwood). 2014 Mar;33(3):493-501. doi: 10.1377/hlthaff.2013.0060. Epub 2014 Feb 12.

PMID:
24522551
13.

Value-based insurance design: quality improvement but no cost savings.

Lee JL, Maciejewski M, Raju S, Shrank WH, Choudhry NK.

Health Aff (Millwood). 2013 Jul;32(7):1251-7. doi: 10.1377/hlthaff.2012.0902. Review.

14.

Evaluation of value-based insurance design with a large retail employer.

Kim YA, Loucks A, Yokoyama G, Lightwood J, Rascate K, Serxner SA.

Am J Manag Care. 2011 Oct;17(10):682-90.

PMID:
22106461
15.

Impact of decreasing copayments on medication adherence within a disease management environment.

Chernew ME, Shah MR, Wegh A, Rosenberg SN, Juster IA, Rosen AB, Sokol MC, Yu-Isenberg K, Fendrick AM.

Health Aff (Millwood). 2008 Jan-Feb;27(1):103-12. doi: 10.1377/hlthaff.27.1.103.

16.

Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment.

Schneeweiss S, Patrick AR, Maclure M, Dormuth CR, Glynn RJ.

Circulation. 2007 Apr 24;115(16):2128-35. Epub 2007 Apr 9.

17.

Value-based insurance design: embracing value over cost alone.

Fendrick AM, Chernew ME, Levi GW.

Am J Manag Care. 2009 Dec;15(10 Suppl):S277-83.

18.

The effect of incentive-based formularies on prescription-drug utilization and spending.

Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Frank RG.

N Engl J Med. 2003 Dec 4;349(23):2224-32.

19.

Can broader diffusion of value-based insurance design increase benefits from US health care without increasing costs? Evidence from a computer simulation model.

Braithwaite RS, Omokaro C, Justice AC, Nucifora K, Roberts MS.

PLoS Med. 2010 Feb 16;7(2):e1000234. doi: 10.1371/journal.pmed.1000234.

20.

The impact of value-based benefit design on adherence to diabetes medications: a propensity score-weighted difference in difference evaluation.

Zeng F, An JJ, Scully R, Barrington C, Patel BV, Nichol MB.

Value Health. 2010 Sep-Oct;13(6):846-52. doi: 10.1111/j.1524-4733.2010.00730.x.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk